A Pilot Study for Adaptation of Neospot Device for Health Care at Primary Health Facilities in Kenya

Sponsor
Neopenda, PBC (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT06132633
Collaborator
Amref Health Africa (Other)
159
1
1
4
39.7

Study Details

Study Description

Brief Summary

Neospot device is a 5-in-1 wearable vital signs monitor designed to measure temperature, blood pressure, pulse rate (PR), respiratory rate (RR) and blood oxygen saturation (SPO2). We propose to study the experiences of patients and nurses regarding spot measurement of vital signs at the outpatient department in primary care facilities in Kenya. The study aims to investigate the capability, opportunity, and motivation of nurses to use the Neospot device for vital signs measurement in level 3 facilities in Kenya by validating the accuracy of the Neospot and assessing the experience of patients while using the Neospot, the study also aims to assess the experiences of nurses as they use the Neospot and determine how the Neospot affects their workflow.

Condition or Disease Intervention/Treatment Phase
  • Device: Neospot vitals measurement
N/A

Detailed Description

This study intends to investigate the experiences of both nurses and patients in the use of a specific brand of such a device known as the 'neospot' device in various sub county, health centres in Kenya. The study also aims at finding out whether the device affects the rate and efficiency of how nurses work in these facilities.

The study will apply a cross sectional design, three facilities will be used as the sampling frame two urban facilities from Nairobi County and one peri urban rural facility from Kajiado county. The participants will be selected randomly. Data will be obtained from a total of 159 randomly selected patients, all the nurses who will be on duty will also be included as participants in the study and the team leaders will be interviewed as key informants for qualitative data. Quantitative data will be analysed using SPSS version 24 for descriptive and inferential statistics, NVIVO software will be used to analyse the qualitative data to determine the themes. Study Duration: Data collection, analysis and report writing will take 4 ½ months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
159 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This is a cross-sectional study design. All participants receive the same intervention of our Neospot vitals measurements.This is a cross-sectional study design. All participants receive the same intervention of our Neospot vitals measurements.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Pilot Study for the Adaptation of Neospot Device for Health Care Among Out-Patients at Primary Health Facilities in Nairobi and Kajiado Counties, Kenya
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neospot Vitals Measurement

Neospot is a 5-in-1 wearable vitals measurement device designed to measure temperature, blood pressure, pulse rate, respiratory rate and blood oxygen saturation. For the standard of care vitals measurement, conventional vital signs will be measured using mercury blood pressure cuffs and infrared or mercury thermometers for blood pressure and temperature respectively, pulse oximeter for oxygen saturation and a 1-minute count of heart rate and breathing rate.

Device: Neospot vitals measurement
Vitals of participants in the intervention group will be measured using neospot alongside standard of care measurement.

Outcome Measures

Primary Outcome Measures

  1. Capability, opportunity and motivation of nurses to use the Neospot device for vital signs measurement [From enrolment, monitoring, data extraction and analysis over a period of 4 months]

    Number of nurses reporting positive experiences and improved workflow as a result of utilizing the neospot product as responded in surveys

Secondary Outcome Measures

  1. Accuracy of vitals measurement of Neospot device compared to traditional equipment [From enrolment, monitoring, data extraction and analysis over a period of 4 months]

    We want to validate the accuracy of the Neospot device to measure temperature, SPO2, pulse rate and respiratory rate by comparing similarities and differences to the traditional devices vital signs readings

  2. Experiences of patients using the Neospot vitals measurement device [From enrolment, monitoring, data extraction and analysis over a period of 4 months]

    Number of patients reporting positive experience with our Neospot device through surveys

  3. Acceptability of Neospot device by nurses for adoption in health facilities [From enrolment, monitoring, data extraction and analysis over a period of 4 months]

    Number of nurses willingness to adopt the use the Neospot device as their primary vital sign measurement tool post utilization, determined through surveys

  4. Effects of Neospot vitals measurement device on nurses' workflow [From enrolment, monitoring, data extraction and analysis over a period of 4 months]

    Number of nurses reporting positive impact of the Neospot device on efficiency and improved workflow through surveys

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants between 18 and 70 years of age

  • In stable condition

  • Willing to give consent to participate in the study

Exclusion Criteria:
  • Very ill and unstable patients who need emergency care

  • Patients with medical conditions that are characterized by rapid changes in vital signs such as thyroid disorders

  • Patients who have skin lesions on the forehead where the device is to be fixed

Contacts and Locations

Locations

Site City State Country Postal Code
1 Langata, Kianda 42 and Matasia Health Centre Nairobi Kenya 00100

Sponsors and Collaborators

  • Neopenda, PBC
  • Amref Health Africa

Investigators

  • Principal Investigator: Jesse Oyieke, Amref International University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Neopenda, PBC
ClinicalTrials.gov Identifier:
NCT06132633
Other Study ID Numbers:
  • P1339/2023
First Posted:
Nov 15, 2023
Last Update Posted:
Nov 15, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Neopenda, PBC

Study Results

No Results Posted as of Nov 15, 2023